Coronavirus: Commission approves contract with CureVac to ensure access to a potential vaccine
Date of publication: 17-11-2020
The European Commission has approved a fifth contract with the European pharmaceutical company CureVac, which provides for the initial purchase of 225 million doses on behalf of all EU Member States, plus an option to request up to a further 180 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19. Źródło: https://ec.europa.eu
